Company / Book Value per Share
Beam Therapeutics Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$12.171
FY2025
5-year range
$8.771 / $12.171
FY2021-FY2025
Trend
+38.8%
vs FY2024
Sector context
#47 of 209
Health Care
What the data says
Beam Therapeutics Inc.'s book value per share of $12.171 is higher than 78% of companies in the Health Care sector (FY2025). Book Value per Share has fluctuated over the past 7 years, ranging from -$31.037 in FY2019 to $12.171 in FY2025.
Based on SEC 10-K filings.
$12.171 in FY2025 with a 3-year CAGR of +5.8%. Top quartile in the Health Care sector.
Remained stable around $12.171 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-93.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, book value per share increased 38.8% year-over-year.
- Ranks #47 out of 209 companies in the Health Care sector.
- Lowest book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.171 | +38.8% |
| FY2024 | $8.771 | -27.0% |
| FY2023 | $12.021 | +16.8% |
| FY2022 | $10.29 | -14.9% |
| FY2021 | $12.089 | +175.4% |
| FY2020 | -$16.026 | +48.4% |
| FY2019 | -$31.037 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026